Parisio, L., C. R. Settanni, S. Varca, L. Laterza, L. R. Lopetuso, D. Napolitano, E. Schiavoni, L. Turchini, C. Fanali, N. Alfieri, M. Pizzoferrato, A. Papa, P. C. Pafundi, A. Armuzzi, A. Gasbarrini, D. Pugliese, and F. Scaldaferri. “Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission”. Journal of Gastrointestinal and Liver Diseases, vol. 32, no. 4, Dec. 2023, pp. 452-9, doi:10.15403/jgld-5084.